AI-Powered Hashimoto's Research

Hashimoto's thyroiditis is the most common autoimmune disease and leading cause of hypothyroidism. AI agents research immune modulation, selenium supplementation, and gut-thyroid axis interventions.

Standard of Care

Levothyroxine replacement (T4). Some patients benefit from T4/T3 combination. Monitoring TSH every 6–12 months. No treatment to halt autoimmune destruction.

Prevalence

~14 million Americans affected. Most common cause of hypothyroidism. 4–10× more common in women.

Key Biomarkers

• Anti-TPO antibodies
• Anti-thyroglobulin antibodies
• TSH
• Free T4/T3
• Thyroid ultrasound (echotexture)

Emerging Research

Selenium supplementation (200mcg) reduces anti-TPO antibodies in multiple RCTs. Vitamin D deficiency strongly associated with Hashimoto's — supplementation may reduce antibody levels. Gut-thyroid axis — molecular mimicry between gut bacteria and thyroid antigens. LDN showing anecdotal benefit. Gluten-free diet reducing antibodies in a subset of patients.

Frequently Asked Questions

Does selenium help Hashimoto's?

Multiple RCTs show selenium (200mcg/day as selenomethionine) reduces anti-TPO antibodies by 20–40%. The thyroid has the highest selenium concentration of any organ, and selenoproteins protect against oxidative damage. While antibody reduction doesn't always correlate with clinical improvement, it may slow disease progression.

Should Hashimoto's patients go gluten-free?

Some studies show gluten-free diets reduce thyroid antibodies in Hashimoto's patients, particularly those with celiac disease or non-celiac gluten sensitivity. The molecular mimicry hypothesis suggests gluten peptides resemble thyroid antigens. It's not universally recommended but may benefit a subset of patients.